Dr. Giordano meets Speaker Nancy Pelosi, De Laurentiis & Petrone at the 47th anniversary of NIAF
Washington D.C. Professor Antonio Giordano founder of Sbarro Health Research …
Post & News
Cellular Cilium an Early Sign of Mesothelioma Differentiation
As Published on Newswise — A new study investigated the …
Cellular Cilium an Early Sign of Mesothelioma Differentiation Read More »
Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Original Newswise post Newswise — Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors …
Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients Read More »
Among the causes of type 1 diabetes is a newly discovered bacterium
Analyzing the inflammatory profile of 54 patients who underwent biopsy, …
Among the causes of type 1 diabetes is a newly discovered bacterium Read More »
Predicting Outcomes for Rare Form of Bladder Cancer with Metastatic Tumors
Original Newswise post Newswise — A team of investigators from …
Predicting Outcomes for Rare Form of Bladder Cancer with Metastatic Tumors Read More »
Molecular Medicine Review Reveals the Role of IGF in Cancer, Other Proliferative Disease
Newswise — Studies suggest that Insulin-Like Growth Factor (IGF) plays …
Molecular Medicine Review Reveals the Role of IGF in Cancer, Other Proliferative Disease Read More »
Immunotherapy Covered in Special Edition of Current Clinical Pathology
Newswise — In the latest Current Clinical Pathology publication on …
Immunotherapy Covered in Special Edition of Current Clinical Pathology Read More »
‘One Health’ Approach Is Necessary to Address Rising Environmental Causes of Childhood Cancers
Editorial by Prof. Philip Landrigan, Director of the Global Public …
(SHRO) Drug Repurposing Identifies New Candidates to Treat Mesothelioma
Newswise — A group of researchers including Antonio Giordano, M.D., …
(SHRO) Drug Repurposing Identifies New Candidates to Treat Mesothelioma Read More »
Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology
Original Newswise post There is a growing awareness that the …